PHOENIX group becomes FMD compliant with Movilitas
Falsified medicines pose a serious health risk to patients.
Body
Falsified Medicines Directive (FMD) significantly challenged PHOENIX group as all its business areas were affected by the directive.
In particular, the company’s FMD requirements for wholesale and 3PL activities were challenging to fulfil. They needed a solution which allowed capture of the current status of those medicines that a wholesaler has to scan according to FMD.
Movilitas.Cloud proved to be the right solution. It is not only connected to the European Medicines Verification System (EMVS) and to all 32 National Medicine Verification Systems (NMVSs) in Europe, but also acts as a connection between PHOENIX’s systems and the systems of partners.
